Interní Med. 2010; 12(1): 33-35

Combination treatment in neovascular macular degeneration

doc.MUDr.Petr Souček, Ph.D., MUDr.Ilona Součková, Ph.D.
Oční klinika FNKV, Praha

This article reviews pathogenesis, symptoms and clinical picture of neovascular age related macular degeneration. The most modern

treatment is combination of verteporfin and ranibizumab. Its principles are described using citations. Results were evaluated on own

study group of 82 eyes of 80 patients. Improvement of functional and anatomical features was statistically significant. The activity of

the disease was halted for more than 4 months in 68 % of cases.

fluorescein angiography.

Keywords: verteporfin, ranibizumab, neovascular macular degeneration, choroidal neovascularization, optical coherence tomography,

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Souček P, Součková I. Combination treatment in neovascular macular degeneration. Interní Med. 2010;12(1):33-35.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cihelková I, Souček P. Atlas makulárních chorob. Atlas of macular diseases. 1. vydání. Praha: Galén/Karolinum, 2005. 521 s.
    2. Souček P. Laserová terapie věkem podmíněné makulární degenerace, poznámky pro klinickou praxi. In Kuchynka P. (Ed.). Trendy soudobé oftalmologie, I. svazek, Praha: Galén, 2000: s. 127-152.
    3. Souček P, Cihelková I. Diagnostika a terapie chorob makuly. Postgraduální medicína 2002, 4 (7): 774-782.
    4. Souček P, Boguszaková J, Gajdošíková Z, et al. Diagnostika, sledování a laserová léčba klasické formy choroidální neovaskularizace u pacientů s věkem podmíněnou makulární degenerací. Čs. Oftal., 1997; 53(2): 94-100.
    5. Cihelková I, Souček P. Nálezy na optické koherentní tomografii u pacientů s makulární degenerací léčených pomocí fotodynamické terapie s preparátem Visudyne. Čes. a slov. Oftal., 2003; 59(4): 250-256.
    6. Souček P, Cihelková I. Visudyne therapy in macular degeneration with predominantly classic subfoveal choroidal neovascularization. In Ioseliani OR, (Ed.). Focus on macular degeneration research, New York: Nova Science Publishers, Inc., 2004: 241-252.
    7. Souček P. Léčba laserem při neovaskulární formě věkem podmíněné makulární degenerace. Lékařské listy, 2000; 49(33): 5.
    8. ANCHOR Study Group: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology, 2009; 116(1): 57-65. Go to original source... Go to PubMed...
    9. Azab M, Boyer DS, Bressler NM, et al. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol, 2005; 123: 448-457. Go to original source... Go to PubMed...
    10. Souček P, Cihelková I. Treatment of macular degeneration (A controlled case). Neuroendocrinology Letters, 2002; 23(4): 370-372. Go to PubMed...
    11. Souček P, Boguszaková J, Cihelková I. Fotodynamická terapie s preparátem Visudyne u makulární degenerace se subfoveolárně uloženou převážně klasickou choroidální neovaskularizací. Čes. a slov. Oftal., 2002; 58(2): 89-97. Go to original source...
    12. Souček P. Photodynamic therapy with verteporfin in predominantly classic subfoveal choroidal neovascularization in age-related and myopic macular degeneration. Acta Photodynamica, 2003; 1(1): 6-13. Go to original source...
    13. Souček P, Cihelková I. Fotodynamická terapie s verteporfinem v éře anti-VEGF. Farmakoterapie 2007; 3(5): 523-528.
    14. Souček P, Cihelková I. Fotodynamická terapie s verteporfinem u převážně klasické subfoveolární choroidální neovaskularizace - řešení akutních forem makulární degenerace. In Rozsíval P. (Ed.). Trendy soudobé oftalmologie, III. svazek, Praha: Galén, 2006: s. 197-217.
    15. Souček P, Součková I. Verteporfin s ranibizumabem u neovaskulární makulární degenerace. Čes. a slov. Oftal., 2008; 64(4): 135-140.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.